Stifel Nicolaus analyst Shlomo Rosenbaum maintained a Buy rating on IQVIA Holdings (IQV – Research Report) yesterday and set a price target of $288.00. The company’s shares closed yesterday at $227.88.
According to TipRanks, Rosenbaum is a 4-star analyst with an average return of 4.9% and a 55.84% success rate. Rosenbaum covers the Industrials sector, focusing on stocks such as Equifax, TransUnion, and First Advantage.
In addition to Stifel Nicolaus, IQVIA Holdings also received a Buy from Bank of America Securities’s Michael Ryskin in a report issued on May 3. However, on May 2, Robert W. Baird reiterated a Hold rating on IQVIA Holdings (NYSE: IQV).
IQV market cap is currently $41.75B and has a P/E ratio of 31.25.
Based on the recent corporate insider activity of 34 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of IQV in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IQVIA Holdings (IQV) Company Description:
North Carolina-based IQVIA Holdings, Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
